Abstract:Key PointsThe liver provides a useful generic model of inflammation and repair, showing the complex interplay between the epithelial, inflammatory, myofibroblast and extracellular matrix (ECM) components of the mammalian wound-healing response. In almost all situations, fibrosis is preceded by inflammation and elements of both the innate and adaptive immune systems are crucial in regulating the fibrotic process.Following liver injury, pro-inflammatory mediators that are generated by cellular damage and stimulated immune cells, as well as growth factors and cytokines (including platelet-derived growth factor, connective tissue growth factor, transforming growth factor-β and interleukin-13), activate mesenchymal precursor cells in tissues and induce their transdifferentiation into myofibroblasts. Myofibroblasts are master regulators of the fibrotic response as a result of their acquisition of scar-producing, proliferative, migratory, contractile, immunomodulatory and phagocytic properties.Recent studies have used bone marrow transplantation techniques in reporter mice to show that, regardless of the aetiology or the duration of the injury, liver myofibroblasts are almost exclusively derived from the activation of resident mesenchymal cells. Perpetuation of myofibroblast fibrogenic activity is mediated through several positive feedback loops, involving the autocrine and paracrine effects of cytokines and growth factors, and cell–cell and cell–matrix interactions. Myofibroblasts themselves function as innate immune cells.The balance of T helper 1 (TH1) cell-mediated and TH2 cell-mediated adaptive immune responses, the influence of unconventional T cell subsets and the equilibrium between different pro-inflammatory (that is, pro-fibrotic) and pro-resolution macrophage populations determine whether the outcome of tissue injury is homeostatic and self-limited or whether it results in pathogenic scarring.Liver fibrosis in rodents and humans is a dynamic, bidirectional process that has an inherent capacity for recovery and remodelling. The loss of myofibroblasts from the hepatic scar and a crucial switch in macrophage phenotype to a pro-resolution cell type are important events in the regression of liver fibrosis that facilitate remodelling of the ECM.A considerable number of tractable therapeutic targets have been identified in liver fibrosis, but clinical trials of anti-fibrotic therapies have so far been unsuccessful. Identification of the core pathways in fibrosis is likely to yield greater success in clinical translation.

Relevance of mast cells and hepatic lobule innervation to liver injury

The Etiology of Liver Damage Imparts Cytokines Transforming Growth Factor Beta 1 or Interleukin-13 As Driving Forces in Fibrogenesis

Immunocytochemical study on the liver innervation in patients with cirrhosis

The Hepatic Nerves Regulated Inflammatory Effect in the Process of Liver Injury: Is Nerve the Key Treating Target for Liver Inflammation?

Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis

Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis

Liver fibrosis and repair: immune regulation of wound healing in a solid organ

Origin of myofibroblasts in the fibrotic liver in mice

Pathophysiology of Liver Fibrosis

Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy

From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells

Liver fibrosis: mechanisms of immune-mediated liver injury

Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation

Lymphocyte–hepatic stellate cell proximity suggests a direct interaction

Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities

Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver.

Hepatic inflammation and fibrosis: Functional links and key pathways

Liver fibrosis and inflammation. A review

Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury

Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis

Crosstalk network among multiple inflammatory mediators in liver fibrosis